Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca reports initial results from the ongoing MYSTIC trial in Stage IV lung cancer
-
AstraZeneca and Merck establish strategic oncology collaboration
-
H1 2017 Results
-
Faslodex receives EU approval as first-line therapy for advanced breast cancer
-
Kyntheum approved in the EU for the treatment of adults with moderate-to-severe plaque psoriasis
-
Faslodex (fulvestrant) receives positive CHMP opinion for use in 1st-line hormone receptor-positive advanced breast cancer
-
AstraZeneca presents new data underpinning safety profile and real-world CV outcomes of Farxiga at ADA 2017
-
AstraZeneca to present scientific advances in cardiovascular and metabolic diseases at 2017 ADA Scientific Sessions
-
AstraZeneca enters agreement with Grünenthal to divest rights to migraine treatment Zomig
-
Lynparza significantly reduces the risk of disease worsening or death in patients with BRCA-mutated metastatic breast cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
